TPG inks $1.9bn pharma take-private

The firm's buyout group will acquire listed pharmaceutical company Par Pharmaceutical. TPG also has investments in several pharmaceutical companies through its TPG Biotech portfolio.

PRIVATE CREDIT

Register to unlock this content

• Daily global private credit news and market intelligence
• Expertly curated insights that keep you ahead of the market
• Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
• Access to proprietary research and reports
• Selected fund performance and investor activity data

Register nowFind out more

DealsPeopleNorth AmericaFund Management